QT Imaging (NASDAQ:QTI) versus Establishment Labs (NASDAQ:ESTA) Head to Head Survey

Establishment Labs (NASDAQ:ESTA) and QT Imaging (NASDAQ:QTI) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Valuation and Earnings

This table compares Establishment Labs and QT Imaging”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08 million	9.26	-$51.06 million	($1.31)	-50.06
QT Imaging	$18.92 million	1.84	-$21.08 million	($1.57)	-1.61

QT Imaging has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Establishment Labs and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
QT Imaging	-77.25%	-1,202.69%	-46.76%

Institutional and Insider Ownership

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 25.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and target prices for Establishment Labs and QT Imaging, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1	0	8	0	2.78
QT Imaging	1	1	1	0	2.00

Establishment Labs presently has a consensus price target of $100.25, indicating a potential upside of 52.87%. Given Establishment Labs’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Establishment Labs is more favorable than QT Imaging.

Summary

Establishment Labs beats QT Imaging on 10 of the 13 factors compared between the two stocks.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.